GLP-1 Drugs Spur Dry Mouth and Reflux in Up to 24% of Users
Updated
Updated · Medical Brief · Jun 24
GLP-1 Drugs Spur Dry Mouth and Reflux in Up to 24% of Users
3 articles · Updated · Medical Brief · Jun 24
Summary
Dry mouth has emerged as the most common oral side effect tied to GLP-1 drugs, with dentists also reporting bad breath, altered taste, tooth sensitivity, cavities and gum disease.
Delayed gastric emptying appears to drive many of those problems by promoting bacterial overgrowth, sulphur burps and reflux, while vomiting affects up to 24% of users and can erode enamel.
More than 200,000 patient records in one recent analysis showed GLP-1 users were 32.9% more likely to develop gastro-oesophageal reflux disease, adding another pathway to odour and tooth damage.
Semaglutide products such as Ozempic and Wegovy may cause more gastrointestinal and oral adverse effects than other GLP-1 drugs, though researchers say direct evidence remains limited.
American Dental Association guidance focuses on symptom control—water, xylitol gum, saliva substitutes, fluoride products and delayed brushing after vomiting—rather than stopping the medication.